DE3163775D1 - Compounds containing beta-lactams - Google Patents

Compounds containing beta-lactams

Info

Publication number
DE3163775D1
DE3163775D1 DE8181305871T DE3163775T DE3163775D1 DE 3163775 D1 DE3163775 D1 DE 3163775D1 DE 8181305871 T DE8181305871 T DE 8181305871T DE 3163775 T DE3163775 T DE 3163775T DE 3163775 D1 DE3163775 D1 DE 3163775D1
Authority
DE
Germany
Prior art keywords
lactams
compounds containing
containing beta
beta
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181305871T
Other languages
English (en)
Inventor
John Barry Harbridge
Irene Stirling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE3163775D1 publication Critical patent/DE3163775D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE8181305871T 1980-12-23 1981-12-14 Compounds containing beta-lactams Expired DE3163775D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8041274 1980-12-23

Publications (1)

Publication Number Publication Date
DE3163775D1 true DE3163775D1 (en) 1984-06-28

Family

ID=10518211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181305871T Expired DE3163775D1 (en) 1980-12-23 1981-12-14 Compounds containing beta-lactams

Country Status (12)

Country Link
US (1) US4562182A (de)
EP (1) EP0055062B1 (de)
JP (1) JPS57130984A (de)
AU (1) AU7876981A (de)
CA (1) CA1167042A (de)
DE (1) DE3163775D1 (de)
ES (1) ES508208A0 (de)
GB (1) GB2089794B (de)
GR (1) GR77314B (de)
NZ (1) NZ199200A (de)
PT (1) PT74168B (de)
ZA (1) ZA818580B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3363281D1 (en) * 1982-09-11 1986-06-05 Beecham Group Plc Intermediates for clavulanic-acid derivatives
EP0127636A1 (de) * 1982-11-25 1984-12-12 Beecham Group Plc Beta-lactame enthaltende verbindungen
CN1040799C (zh) * 1989-08-25 1998-11-18 株式会社亚玛托亚商会 从原稿的图象制作复制图象时的调色变换方法
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205682A1 (es) * 1970-06-11 1976-05-31 Philips Nv Metodo de produccion de ester (2-dimetilaminoetil) de acido (4-cloro-alfa - metilbenciliden) amino-oxiacetico y sus sales de adicion de acido formadas con acidos farmacologicamente aceptables
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US4399142A (en) * 1973-05-03 1983-08-16 Smith Kline & French Laboratories Limited Pharmacologically active compounds
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
AU503489B2 (en) * 1975-10-13 1979-09-06 Beecham Group Limited Substituted aminodeoxy clavulanic acid
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
GB1515241A (en) * 1976-01-27 1978-06-21 Beecham Group Ltd Beta-lactam antibiotics
IL51267A (en) * 1976-01-31 1979-12-30 Beecham Group Ltd Clavulanic acid thioethers their preparation and pharmaceutical compositions containing them
GB1529913A (en) * 1976-02-04 1978-10-25 Beecham Group Ltd Beta-lactam compounds
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
BE858858A (fr) * 1976-10-16 1978-03-20 Fisons Ltd Composition de cromoglycate disodique
GB1599907A (en) * 1977-04-26 1981-10-07 Glaxo Lab Ltd Isoindolines
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
EP0007152A1 (de) * 1978-04-28 1980-01-23 Beecham Group Plc Beta-Lactam Antibiotika, Herstellung und Verwendung
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0007753B1 (de) * 1978-08-02 1982-08-25 Beecham Group Plc Antibakterielle Beta-Lactam-Verbindungen, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2966349D1 (en) * 1978-09-09 1983-12-01 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
DE2849646A1 (de) * 1978-11-16 1980-06-04 Hoechst Ag Thienylbenzoesaeurederivate und verfahren zu ihrer herstellung
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents
CA1152517A (en) * 1979-06-29 1983-08-23 Ian H. Coates Heterocyclic compounds, processes for their preparation and their use
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
DK344180A (da) * 1979-08-09 1981-02-10 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse
US4402949A (en) * 1979-11-12 1983-09-06 Sandoz Ltd. Stable solutions of hydrogenated ergotalkaloids
US4315935A (en) * 1980-04-14 1982-02-16 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use
US4317826A (en) * 1980-05-27 1982-03-02 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4 tetrahydroisoquinolyl]disulfonylimides and antiallergic compositions and method of use
IT1150955B (it) * 1980-06-06 1986-12-17 Lepetit Spa Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
EP0043197A1 (de) * 1980-07-02 1982-01-06 Beecham Group Plc Beta-Lactam-Antibiotikum, Herstellung und Verwendung
US4321254A (en) * 1980-09-26 1982-03-23 Smithkline Corporation Antiallergic imidodisulfamides
US4385047A (en) * 1981-01-05 1983-05-24 Smithkline Beckman Corporation Antiallergic imidodisulfamides
US4350685A (en) * 1981-02-06 1982-09-21 Smithkline Corporation Antiallergic imidodisulfamides
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
US4401665A (en) * 1981-04-14 1983-08-30 Bristol-Myers Company Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US4402976A (en) * 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism
US4396619A (en) * 1981-09-08 1983-08-02 Eli Lilly And Company Cephalosporin betaines
US4396620A (en) * 1981-09-08 1983-08-02 Eli Lilly And Company Cephalosporin quinolinium betaines
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4406898A (en) * 1981-09-08 1983-09-27 Eli Lilly And Company Oxazole and oxadiazole cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4402955A (en) * 1981-10-02 1983-09-06 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4397845A (en) * 1982-05-19 1983-08-09 The Upjohn Company Lincomycin 3-(5'-adenylate) as anesthetic

Also Published As

Publication number Publication date
CA1167042A (en) 1984-05-08
EP0055062B1 (de) 1984-05-23
NZ199200A (en) 1984-07-31
GB2089794B (en) 1984-09-05
ZA818580B (en) 1982-11-24
EP0055062A1 (de) 1982-06-30
PT74168A (en) 1982-01-01
GR77314B (de) 1984-09-11
ES8307252A1 (es) 1983-07-01
ES508208A0 (es) 1983-07-01
PT74168B (en) 1983-05-17
JPS57130984A (en) 1982-08-13
AU7876981A (en) 1982-07-01
US4562182A (en) 1985-12-31
GB2089794A (en) 1982-06-30

Similar Documents

Publication Publication Date Title
GB2081717B (en) Hereocyclic compounds
JPS56143247A (en) 4-chlorothiazolyl containing compound
JPS5767568A (en) Benzisoselenazolone compound
JPS57120588A (en) Nortropanol compound
DE3171475D1 (en) Aryl-phenyl-acetylene compounds
JPS57120575A (en) Imidazolylphenylamidine compound
DE3362221D1 (en) Azolylstyryl compounds
JPS5724328A (en) Dienylmethacrylate compound
GB2083046B (en) Bestatin-related compounds
GB2119368B (en) Substituted thiopyranopyrimidine compounds
PT72752B (en) Compounds
DE3363786D1 (en) Dioxocyclobutene compounds
JPS56152469A (en) Substituted triarylthiazole compound
DE3163775D1 (en) Compounds containing beta-lactams
GB2067992B (en) Malonamidooxadethiacephem compounds
JPS5749666A (en) Helichromic compound
DE3162041D1 (en) Hydrouracil compounds
JPS56125389A (en) Spiro-dihydrobenzofuran compound
JPS5794051A (en) Halotriazinyl-containing compound
GB2082577B (en) Polyazaheterocyclic compounds
ZA812675B (en) Mycotoxin-binding compound
DE3160271D1 (en) Monoalkyl-fluorotin compounds
JPS5795972A (en) 2-guanidino-4-heteroarylthiazole compound
JPS5785396A (en) 4-carbamoyloxy-oxazaphosphorine compound
GB2070597B (en) Sulphonium compounds

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee